{{Rsnum
|rsid=4969170
|Chromosome=17
|position=78364457
|Orientation=plus
|GMAF=0.4192
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=RP11-806H10.4
|Gene_s=RP11-806H10.4
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 13.3 | 46.0 | 40.7
| HCB | 89.1 | 10.9 | 0.0
| JPT | 72.3 | 22.3 | 5.4
| YRI | 55.5 | 36.3 | 8.2
| ASW | 43.9 | 42.1 | 14.0
| CHB | 89.1 | 10.9 | 0.0
| CHD | 86.2 | 13.8 | 0.0
| GIH | 26.7 | 45.5 | 27.7
| LWK | 46.8 | 42.2 | 11.0
| MEX | 13.8 | 55.2 | 31.0
| MKK | 36.8 | 43.2 | 20.0
| TSI | 16.7 | 46.1 | 37.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=23133602
|Title=Pharmacogenetics of Efficacy and Safety of HCV Treatment in HCV-HIV Coinfected Patients: Significant Associations with IL28B and SOCS3 Gene Variants
|OA=1
}}

{{PMID Auto
|PMID=23490372
|Title=Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C
}}

{{PMID Auto
|PMID=16402267
|Title=Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins.
|OA=1
}}

{{PMID Auto
|PMID=16685656
|Title=Elevated expression and genetic association links the SOCS3 gene to atopic dermatitis.
|OA=1
}}

{{PMID Auto
|PMID=17881539
|Title=Elevated expression and polymorphisms of SOCS3 influence patient response to antiviral therapy in chronic hepatitis C.
}}

{{PMID Auto
|PMID=19074178
|Title=Gene expression and hepatitis C virus infection.
|OA=1
}}

{{PMID Auto
|PMID=19077438
|Title=Analysis of 30 genes (355 SNPS) related to energy homeostasis for association with adiposity in European-American and Yup'ik Eskimo populations.
|OA=1
}}

{{PMID Auto
|PMID=19083014
|Title=Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study.
|OA=1
}}

{{PMID Auto
|PMID=19604093
|Title=Genetic polymorphisms, their allele combinations and IFN-beta treatment response in Irish multiple sclerosis patients.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}
{{on chip | NatGeo2}}